CLB Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.…
Industry Peers
Oil & Gas Equipment & ServicesKey Statistics
About Core Laboratories (NYSE: CLB)
›
Core Laboratories (NYSE: CLB) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Oil & Gas Equipment & Services industry, part of the Energy sector, and reports about 3,300 employees.
The shares were at 8.400 USD on 19 November 2026, down 45.0% over 52 weeks. Its 52-week range is 8.120 USD to 20.36 USD: the price is 58.7% below the high and 3.4% above the low.
At a market capitalisation of 384.91M USD, it trades at 24.7 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 20 largest Oil & Gas Equipment & Services peers is 16.0, a premium of 54% for CLB. It pays a dividend yielding 0.47% (it pays out 12% of its earnings), against a median of 2.85% among the dividend payers in that peer group.
Core Laboratories reports return on equity of 11.2%, an operating margin of 7.5% and revenue down 1.8% year over year.
Its debt exceeds its cash by 140.60M USD, a debt-to-equity ratio of 0.62. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 3 analysts cover the stock; their mean price target of 15.00 USD is 78.6% above the current price. The next earnings report is expected on 3 February 2027.